SOURCE: Informance International

August 23, 2007 09:00 ET

Benchmark Study Reveals Important Insight for Manufacturing Performance in Pharmaceutical Industries

Enterprise Manufacturing Intelligence Data Used to Uncover Strategies of Top Performing Companies

REDWOOD CITY, CA--(Marketwire - August 23, 2007) - High performance pharmaceutical manufacturers outpace their peers in operational metrics such as asset utilization, overall equipment effectiveness (OEE), and operational availability, according to a report published by Informance International, a leader in Enterprise Manufacturing Intelligence (EMI). The six-month study of 50 worldwide pharmaceutical lines uncovered substantial gaps in performance for manufacturers that have granular, real-time visibility and measurement of key metrics versus those that do not.

The study revealed that best-in-class pharmaceutical enterprises outpace laggard performers in:

--  Operational availability by 77%
--  Overall equipment effectiveness by 73%, and
--  Equipment failure by more than triple (7% of capacity vs. 26% for
    laggards)
    

Forging new ground in cross-industry benchmarking, researchers also examined pharmaceutical manufacturing performance in comparison to food and beverage manufacturing and discovered astonishing gaps in performance. They determined that best-in-class pharmaceutical manufacturers lag far behind best-in-class counterparts in the food and beverage industry in numerous metrics.

"Organizations involved in continuous improvement initiatives can benefit from this level of granular information," comments Bikash Chatterjee, President of Pharmatech Associates, a leading consulting firm in pharmaceutical biotech manufacturing process methodology.

Informance benchmark studies are unique because researchers use many months of real-time manufacturing performance data aggregated using the Informance Enterprise Manufacturing Intelligence platform. The highly granular and rich real-time nature of Informance EMI adds a new dimension for external and internal benchmarking initiatives.

"By correlating attributes of best-in-class performers across a variety of metrics, executives have the ability to gain insight and direction," comments John Oskin, Executive Vice President of Informance International. "Organizations can now understand how they stack up against their peers and develop an action plan for operational improvement."

To read the executive summary of this report, visit www.Informance.com/PharmaStudy.

About Informance International

Informance delivers Enterprise Manufacturing Intelligence (EMI) solutions to help clients accelerate operational performance initiatives, drive operating strategies and capture actionable insight; measured by speed-to-value. Clients quickly unlock hidden capacity, increase productivity without additional capital investment, reduce inventory and labor costs, and increase working capital. To learn more, call 1-877-464-6262 or e-mail info@informance.com. For more information, visit www.informance.com or contact:

Contact Information

  • Diane Murray
    Marketing Communications Manager
    Email Contact
    (847) 498-1844 ext. 235